TAK ALG-12.5 (Alogliptin Benzoate 12.5 mg)
Pill with imprint TAK ALG-12.5 is Yellow, Elliptical / Oval and has been identified as Alogliptin Benzoate 12.5 mg. It is supplied by Perrigo New York Inc..
Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TAK ALG-12.5
Alogliptin Benzoate
- Imprint
- TAK ALG-12.5
- Strength
- 12.5 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Perrigo New York Inc.
- National Drug Code (NDC)
- 45802-0103
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 8000,
ferric oxide yellow,
ferrosoferric oxide,
shellac,
butyl alcohol,
alcohol
Note: Inactive ingredients may vary.
Related Images for "TAK ALG-12.5"
More about alogliptin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- En Español
- 8 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
Consumer resources
- Other brands
- Nesina
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.